- Home
- AQST vs GHY Comparison
AQST vs GHY Comparison
Compare AQST & GHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AQST | GHY |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.4M | 445.2M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | AQST | GHY |
|---|---|---|
| Price | $4.05 | $10.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $9.33 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 189.1K |
| Earning Date | 11-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.58% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,430,000.00 | N/A |
| Revenue This Year | $14.58 | N/A |
| Revenue Next Year | $32.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $2.94 | $10.57 |
| 52 Week High | $6.93 | $12.96 |
Technical Indicators
Market Signals| Indicator | AQST | GHY |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 34.41 |
| Support Level | $4.03 | $10.62 |
| Resistance Level | $4.35 | $12.07 |
| Average True Range (ATR) | 0.24 | 0.13 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 29.06 | 27.62 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About GHY PGIM Global High Yield Fund Inc.
PGIM Global High Yield Fund, Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide a high level of current income. The fund seeks to provide a high level of current income by investing in higher-rated, below-investment-grade fixed income instruments of issuers located around the world, including emerging markets.